Company profile for Y-Biologics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Y-Biologics is a biotech company focusing on the discovery & development of novel antibody therapeutics based on its human antibody library Ymax-ABL & Bi-specific antibody platform technology ALiCE. We have successfully secured own human antibody library based on phage display to discover target antibodies and currently have developed 20 antibody candidates in various modalities. Following early work in discovery, we have rece...
Y-Biologics is a biotech company focusing on the discovery & development of novel antibody therapeutics based on its human antibody library Ymax-ABL & Bi-specific antibody platform technology ALiCE. We have successfully secured own human antibody library based on phage display to discover target antibodies and currently have developed 20 antibody candidates in various modalities. Following early work in discovery, we have recently developed novel BsAb platform technology ALiCE (Antibody Like Cell Engager), which has potential to address current unmet needs in fields of immuno-oncology.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
29 Techno 4-ro, Gwanpyeong-dong, Yuseong-gu, Daejeon
Telephone
Telephone
+82-42-867-9971
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/south-korean-biotech-y-biologics-and-french-mid-pharma-pierre-fabre-enter-into-a-worldwide-exclusive-license-agreement-in-the-highly-innovative-field-of-immuno-oncology-301325613.html

PR NEWSWIRE
07 Jul 2021

http://www.pharmabiz.com/NewsDetails.aspx?aid=139816&sid=2

PHARMABIZ
07 Jul 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty